[1. C. Cerchia and A. Lavecchia, Small molecule drugs and targeted therapy for melanoma: Current strategies and future directions, Curr. Med. Chem. 24 (2017) 1–33; https://doi.org/10.2174/092986732466617041416393710.2174/092986732466617041416393728413965]Search in Google Scholar
[2. T. Zhang, Y. R. Suryawanshi, H. M. Woyczesczyk and K. Essani, Targeting melanoma with cancerkilling viruses, Open. Virol. J. 11 (2017) 28–47; https://doi.org/10.2174/187435790171101002810.2174/1874357901711010028542017228567163]Search in Google Scholar
[3. P. Diamantopoulos and H. Gogas, Melanoma immunotherapy dominates the field, Ann. Transl. Med.4 (2016) 269; https://doi.org/10.21037/atm.2016.06.3210.21037/atm.2016.06.32497137927563656]Search in Google Scholar
[4. A. A. Tarhini and S. S. Agarwala, Cutaneous melanoma: available therapy for metastatic disease, Dermatol. Ther. 19 (2010) 19–25; https://doi.org/10.1111/j.1529-8019.2005.00052.x10.1111/j.1529-8019.2005.00052.x16405566]Search in Google Scholar
[5. P. C. Bruijnincx and P. J. Sadler, New trends for metal complexes with anticancer activity, Curr. Opin. Chem. Biol.12 (2008) 197–206; https://doi.org/10.1016/j.cbpa.2007.11.01310.1016/j.cbpa.2007.11.013292302918155674]Search in Google Scholar
[6. Y. Jung and S. J. Lippard, Direct cellular responses to platinum-induced DNA damage, Chem. Rev. 107 (2010) 1387–407; https://doi.org/10.1002/chin.20073127010.1002/chin.200731270]Search in Google Scholar
[7. M. S. Soengas and S. W. Lowe, Apoptosis and melanoma chemoresistance, Oncogene22 (2003) 3138–3151; https://doi.org/10.1038/sj.onc.120645410.1038/sj.onc.120645412789290]Search in Google Scholar
[8. I. E. León, V. Porro, S. Astrada, M. G. Egusquiza, C. I. Cabello, M. Bollati-Fogolin and S. B. Etcheverry, Polyoxometalates as antitumor agents: Bioactivity of a new polyoxometalate with copper on a human osteosarcoma model, Chem. Biol. Interact. 222 (2014) 87–96; https://doi.org/10.1016/j.cbi.2014.10.01210.1016/j.cbi.2014.10.01225451568]Search in Google Scholar
[9. J. Zhao, S. Gou and F. Liu, Potent anticancer activity and possible low toxicity of platinum(II) complexes with functionalized 1,1-cyclobutanedicarboxylate as a leaving ligand, Chemistry20 (2014) 15216–15225; https://doi.org/10.1002/chem.20140409010.1002/chem.20140409025256173]Search in Google Scholar
[10. S. Iglesias, N. Alvarez, M. H. Torre, E. Kremer, J. Ellena, R. R. Ribeiro, R. P. Barroso, A. J. Costafilho, M. G. Kramer and G. Facchin, Synthesis, structural characterization and cytotoxic activity of ternary copper(II)-dipeptide-phenanthroline complexes. A step towards the development of new copper complexes for the treatment of cancer, J. Inorg. Biochem. 139 (2014) 117–123; https://doi.org/10.1016/j.jinorgbio.2014.06.00710.1016/j.jinorgbio.2014.06.00725033418]Search in Google Scholar
[11. J. Lv, T. T. Liu, S. L. Cai, X. Wang, L. Liu and Y. M. Wang, Synthesis, structure and biological activity of cobalt (ii) and copper (ii) complexes of valine-derived Schiff bases, J. Inorg. Biochem.100 (2006) 1888–1896; https://doi.org/10.1016/j.jinorgbio.2006.07.01410.1016/j.jinorgbio.2006.07.01416965817]Search in Google Scholar
[12. V. M. Leovac, G. A. Bogdanović, L. S. Jovanović, L. Joksović, V. Marković, M. D. Joksović, S. M. Denčić, A. Isaković, I. Marković and F. W. Heinemann, Synthesis, characterization and antitumor activity of polymeric copper(II) complexes with thiosemicarbazones of 3-methyl-5-oxo-1-phenyl--3-pyrazolin-4-carboxaldehyde and 5-oxo-3-phenyl-3-pyrazolin-4-carboxaldehyde, J. Inorg. Biochem.105 (2011) 1413–1421; https://doi.org/10.1016/j.jinorgbio.2011.07.02110.1016/j.jinorgbio.2011.07.02121955843]Search in Google Scholar
[13. X. Q. Zhou, Y. Li, D. Y. Zhang, Y. Nie, Z. J. Li, W. Gu, X. Liu, J. L. Tian and S. P. Yan, Copper complexes based on chiral Schiff-base ligands: DNA/BSA binding ability, DNA cleavage activity, cytotoxicity and mechanism of apoptosis, Eur. J. Med. Chem. 114 (2016) 244–256; https://doi.org/10.1016/j.ejmech.2016.02.05510.1016/j.ejmech.2016.02.05526994692]Search in Google Scholar
[14. X. H. Wang, D. Z. Jia, Y. J. Liang, S. L. Yan, Y. Ding, L. M. Chen, Z. Shi, M. S. Zeng, G. F. Liu and L. W. Fu, Lgf-YL-9 induces apoptosis in human epidermoid carcinoma KB cells and multidrug resistant KBv200 cells via reactive oxygen species-independent mitochondrial pathway, Cancer. Lett. 249 (2007) 256–270; https://doi.org/10.1016/j.canlet.2006.09.00810.1016/j.canlet.2006.09.00817055640]Search in Google Scholar
[15. C. Kou, J. Zhao, Y. Li, G. Xu and S. Sun, Acute toxicity test of different doses of copper complex of pyrazolone derivatives in mice, Chin. Hosp. Pharm. J. 36 (2016) 821–825 (In Chinese).]Search in Google Scholar
[16. G. C. Xu, L. Zhang, L. Liu, G. F. Liu and D. Z. Jia, Syntheses, characterization and crystal structures of mixed-ligand Cu(II), Ni(II) and Mn(II) complexes of (1-phenyl-3-methyl-4-propenylidene-5--pyrazolone)-salicylidene hydrazide containing ethanol or pyridine as a co-ligand, Polyhedron27 (2008) 12–24; https://doi.org/10.1016/j.poly.2007.08.04510.1016/j.poly.2007.08.045]Search in Google Scholar
[17. J. Zhao, L. Zhang, J. Li, T. Wu, M. Wang, G. Xu, F. Zhang, L. Liu, J. Yang and S. Sun, A novel pyrazolone-based derivative induces apoptosis in human esophageal cells via reactive oxygen species (ROS) generation and caspase-dependent mitochondria-mediated pathway, Chem. Biol. Interact. 231 (2015) 1–9; https://doi.org/10.1016/j.cbi.2015.02.00410.1016/j.cbi.2015.02.00425684395]Search in Google Scholar
[18. Q. L. Wu, X. P. Wu, Y. J. Liang, L. M. Chen, Y. Ding and L. W. Fu, P-glycoprotein is not involved in pathway of anti-Fas/Fas-induced apoptosis in KBv200 cells, World. J. Gastroenterol.11 (2005) 3544; https://doi.org/10.3748/wjg.v11.i23.354410.3748/wjg.v11.i23.3544431595715962371]Search in Google Scholar
[19. C. Chang, T. Wu, M. Wang, G. Xu and S. Sun, Antitumor effect of cadmium(II) complex of pyrazolone derivatives on melanoma B16 cells in vitro and in vivo, Chin. J. Pharmacol. Toxicol. 31 (2017) 405–413 (In Chinese).]Search in Google Scholar
[20. G. Resta, G. Anania, F. Messina, D. D. Tullio, G. Ferrocci, F. Zanzi, D. Pellegrini, R. Stano, G. Cavallesco, G. Azzena and S. Occhionorelli, Jejuno-jejunal invagination due to intestinal melanoma, World. J. Gastroenterol. 13 (2007) 310; https://doi.org/10.3748/wjg.v13.i2.31010.3748/wjg.v13.i2.310406596417226915]Search in Google Scholar
[21. A. Dayton, K. Selvendiran, S. Meduru, M. Khan, M. L. Kuppusamy, S. Naidu, T. Ka´lai, K. Hideg and P. Kuppusamy, Amelioration of doxorubicin-induced cardiotoxicity by an anticancer-antioxidant dual-function complex, J. Pharmacol. Exp. Ther. 339 (2011) 350–357; https://doi.org/10.1124/jpet.111.18368110.1124/jpet.111.183681319999421799049]Search in Google Scholar
[22. H. Yang, D. Chen, Q. C. Cui, X. Yuan and Q. P. Dou, Celastrol, a triterpene extracted from the chinese “thunder of god vine,” is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice, Cancer. Res. 66 (2006) 4758; https://doi.org/10.1158/0008-5472.can-05-452910.1158/0008-5472.CAN-05-452916651429]Search in Google Scholar
[23. W. Jiang, J. Cao, B. Pan and Y. Yu, Clinical significance of serum vascular endothelial growth factor and b-fibroblast growth factor before and after chemotherapy in patients with small cell lung cancer, Chin. J. Clin. Oncol. 40 (2013) 638–642; https://doi.org/10.3969/j.issn.1000-8179.2013.11.006]Search in Google Scholar
[24. S. Imura, H. Miyake, K. Izumi, S. Tashiro and H. Uehara, Correlation of vascular endothelial cell proliferation with microvessel density and expression of vascular endothelial growth factor and basic fibroblast growth factor in hepatocellular carcinoma, J. Med. Invest. 51 (2004) 202; https://doi.org/10.2152/jmi.51.20210.2152/jmi.51.20215460907]Search in Google Scholar
[25. H. Yao, P. Cui, D. Xu, Y. Liu, Q. Tian and F. Zhang, A water-soluble polysaccharide from the roots of Polygala tenuifolia suppresses ovarian tumor growth and angiogenesis in vivo, Int. J. Biol. Macromol.107 (2018) 713–718; https://doi.org/10.1016/j.ijbiomac.2017.09.04310.1016/j.ijbiomac.2017.09.04328923567]Search in Google Scholar